Press Briefing - News on another Clinical Trial of a COVID-19 Vaccine in Germany (2 October 2020)

Begin

End

The Paul-Ehrlich-Institut is planning a virtual press conference for journalists tomorrow, Friday, 2 October 2020, at 11:00 a.m., with current information on a further clinical trial of a vaccine against SARS-CoV-2 in Germany. As a journalist you can enter the virtual event room from 10:45 am.

Login Data

https://paul-ehrlich-institut.webex.com/paul-ehrlich-institut-en/onstage/g.php?MTID=ef89116dace4113f682effcad408aeda5
Password: COVID-19

Please note: the event language is German, but questions can be asked in English, too.

In order to enable a successful log-in, we ask you to read the technical-organisational instructions for participants carefully and to observe them.